Evidence map›Paper›PMID 16874458›Full record

ArticleCellular & molecular biology letters2006

Erk is involved in the differentiation induced by diallyl disulfide in the human gastric cancer cell line MGC803.

Hui Ling, Liang-Yun Zhang, Qi Su, Ying Song, Zhao-Yang Luo, Xiu Tian Zhou, Xi Zeng, Jie He, Hui Tan, Jing-Ping Yuan

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 37 citations in OpenAlex.

  1. Diallyl disulfide in oncotherapy: molecular mechanisms and therapeutic potentials.Apoptosis : an international journal on programmed cell death · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hui LingCancer Research Institute, Nanhua University, Hengyang City, Hunan Province, China.
Liang-Yun Zhang
Qi Su
Ying Song
Zhao-Yang Luo
Xiu Tian Zhou
Xi Zeng
Jie He
Hui Tan
Jing-Ping Yuan
University of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diallyl disulfide (DADS) is a major constituent of garlic. Previously, we found that DADS both inhibited proliferation in human gastric cancer cells in vitro and in vivo, and induced G2/M arrest. In this study, we investigated whether this differentiation effect was induced by DADS in human gastric cancer MGC803 cells, and whether it was related to an alteration in ERK activity. The results showed that the growth of MGC803 cells was inhibited by DADS. Cells treated with DADS displayed a lower nucleocytoplasmic ratio and tended to form gland and intercellular conjunction structures. The ConA-mediated cell agglutination ratio and cells' ALP specific activity decreased. In MGC803 cells, dye transfer was limited to a few cells neighbouring the dye-injected cell and to a depth of 1-2 layers beneath the scrape site. However, after treatment with DADS, the LY (Lucifer Yellow) was transferred to several cells immediately neighbouring the microinjected cell and to a depth of 2-4 cell layers from the scrape site. This indicated that DADS induced differentiation in MGC803 cells. Western blot analysis revealed that although DADS did not influence the quantity of ERK1/2 protein expressed, it did decrease its phosphorylation in a concentration-dependent manner, compared with the controls. At 30 mg x L(-1), DADS inhibited the activation of ERK1/2 in 15-30 min. These results suggested that the DADS-induced differentiation of MGC803 cells involved an alteration of the ERK1/2 signaling pathway.

Indexed as

AgglutinationAlkaline PhosphataseAllyl CompoundsButadienesCell DifferentiationCell Line, TumorCell SurvivalConcanavalin ADisulfidesHumansMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NitrilesPhosphoproteinsPhosphorylationStomach NeoplasmsAlkaline PhosphataseAllyl CompoundsButadienesConcanavalin Adiallyl disulfideDisulfidesMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3NitrilesPhosphoproteinsU 0126

Identifiers

PMID16874458
PMCPMC6472800
OpenAlexW2111310847

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.